14-day Premium Trial Subscription Sign Up For FreeGet Free

Champions Oncology Stock Forecast NASDAQ:CSBR

$8.14 (-2.05%)

Volume: 2k

Closed: Dec 03, 2021

Hollow Logo Score: -2.935

Champions Oncology Stock Forecast

$8.14 (-2.05%)

Volume: 2k

Closed: Dec 03, 2021

Score Hollow Logo -2.935
Which way will CSBR go? Request
Earnings Date: Dec 13, 2021
Key Stats
Beta 0.95
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 29 and the stock is currently not being overbought or oversold

Champions Oncology stock price ended on $8.14 on Friday after losing 2.05%
(Updated on Dec 03, 2021)

Sell candidate since 2021-11-19 Loss -13.13%

The Champions Oncology stock price fell by -2.05% on the last day (Friday, 3rd Dec 2021) from $8.31 to $8.14. During the day the stock fluctuated 3.56% from a day low at $8.14 to a day high of $8.43. The price has fallen in 6 of the last 10 days and is down by -16.26% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -756 shares and in total, 2 thousand shares were bought and sold for approximately $14.67 thousand.

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $7.84 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -13.81% during the next 3 months and, with a 90% probability hold a price between $6.76 and $8.43 at the end of this 3-month period.

Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, November 30, 2021, and so far it has risen 2.78%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Champions Oncology stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $8.47 and $9.56. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss

Champions Oncology finds support from accumulated volume at $7.92 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.29 between high and low, or 3.56%. For the last week the stock has had a daily average volatility of 6.51%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Champions Oncology stock A Buy?

Champions Oncology holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.935

Predicted Opening Price for Champions Oncology of Monday, December 6, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 6, 2021 Current price
$8.24 $8.14 (Undervalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Aug 03, 2021 "Roth Capital" gave "" rating for CSBR. The price target was set to $10.62+1.1%.

Volatility and Risk
Daily Average Volatility: 6.51 %
Overall Risk: Very High High Medium Low Very Low
6.51 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $10.00
Price: $8.14
Support: $7.92

CSBR Insider Trading Show all Trades



Last 100 transactions
Buy: 2 552 543 | Sell: 2 734 721 (Shares)
Date Action Amount Person Type
Nov 05, 2021 Buy 18 564 Ackerman Joel Option to purchase Common Stock
Nov 05, 2021 Buy 8 045 Breitfeld Philip P. Option to purchase Common Stock
Nov 05, 2021 Buy 13 614 Mendelson Daniel Newman Option to purchase Common Stock
Nov 05, 2021 Buy 8 045 Sidransky David Option to purchase Common Stock
Nov 05, 2021 Buy 14 851 Tobin Scott R Option to purchase Common Stock
Show all Insider Trades


Last 100 transactions
Buy: 2 552 543 | Sell: 2 734 721 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 8.53 4.75 %
8.42 3.39 %
8.35 2.55 %
Current price: 8.14
Support 8.13 -0.17 %
8.06 -1.01 %
7.95 -2.38 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 10.10 24.08 %
10.01 22.97 %
10.00 22.85 %
Current price 8.14
Support 7.92 -2.70%
0 .
0 .

Click to get the best stock tips daily for free!

About Champions Oncology

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized Oncology Solutions (POS) that assist physicians in developing per... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE